Ublituximab
Ublituximab Uses, Dosage, Side Effects, Food Interaction and all others data.
Ublituximab has been used in trials studying the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma, among others.
| Trade Name | Ublituximab |
| Generic | Ublituximab |
| Ublituximab Other Names | Ublituximab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ublituximab
